It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
A major challenge in the application of the CRISPR-Cas13d system is to accurately predict its guide-dependent on-target and off-target effect. Here, we perform CRISPR-Cas13d proliferation screens and design a deep learning model, named DeepCas13, to predict the on-target activity from guide sequences and secondary structures. DeepCas13 outperforms existing methods to predict the efficiency of guides targeting both protein-coding and non-coding RNAs. Guides targeting non-essential genes display off-target viability effects, which are closely related to their on-target efficiencies. Choosing proper negative control guides during normalization mitigates the associated false positives in proliferation screens. We apply DeepCas13 to the guides targeting lncRNAs, and identify lncRNAs that affect cell viability and proliferation in multiple cell lines. The higher prediction accuracy of DeepCas13 over existing methods is extensively confirmed via a secondary CRISPR-Cas13d screen and quantitative RT-PCR experiments. DeepCas13 is freely accessible via http://deepcas13.weililab.org.
Application of CRISPR-Cas13d is limited by the inability to predict on- and off-targets. Here the authors perform CRISPR-Cas13d proliferation screens followed by modeling of Cas13d on- and off-targets; they design a deep learning model, DeepCas13, to predict the on-target activity of a gRNA.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Li, Zexu 2
; Shan, Ruocheng 3 ; Li, Zihan 2
; Wang, Shengnan 2 ; Zhao, Wenchang 2 ; Zhang, Han 2 ; Chao, Lumen 1 ; Peng, Jian 4
; Fei, Teng 2
; Li, Wei 1
1 Children’s National Hospital, Center for Genetic Medicine Research, Washington, USA (GRID:grid.239560.b) (ISNI:0000 0004 0482 1586); George Washington University, Department of Genomics and Precision Medicine, Washington, USA (GRID:grid.253615.6) (ISNI:0000 0004 1936 9510)
2 Northeastern University, National Frontiers Science Center for Industrial Intelligence and Systems Optimization, Key Laboratory of Bioresource Research and Development of Liaoning Province, College of Life and Health Sciences, Shenyang, China (GRID:grid.412252.2) (ISNI:0000 0004 0368 6968)
3 Children’s National Hospital, Center for Genetic Medicine Research, Washington, USA (GRID:grid.239560.b) (ISNI:0000 0004 0482 1586); George Washington University, Department of Computer Science, Washington, USA (GRID:grid.253615.6) (ISNI:0000 0004 1936 9510)
4 University of Illinois at Urbana-Champaign, Department of Computer Science, Urbana, USA (GRID:grid.35403.31) (ISNI:0000 0004 1936 9991)




